Clinical Trial: Characterization of CD180 Protein Expression in Myeloid Hematological Malignancies by Flow Cytometry

U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07895901) titled 'Characterization of CD180 Protein Expression in Myeloid Hematological Malignancies by Flow Cytometry' on Oct. 19.

Brief Summary: CD180 is a cell-surface protein recently identified through proteomic analysis as a potential target of interest in myeloid hematological malignancies. It may have diagnostic and monitoring potential, particularly in acute myeloid leukemia (AML).

This monocentric, non-interventional, retrospective observational study aims to characterize CD180 expression by flow cytometry in pathological hematopoietic cells, particularly in AML, and in normal hematopoietic stem and progenitor cells (CD34+ cells). The stud...